Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue ▴	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
ARDX	Ardelyx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$407.32M	-$61.60M	-15.1%	-36.9%	22.1%	-$0.26
INVA	Innoviva, Inc. Manufacturing · Year ended 2025-12-31 · USD	$411.33M	$271.17M	65.9%	23.1%	14.7%	$3.30
ZLAB	Zai Lab Ltd Manufacturing · Year ended 2025-12-31 · USD	$457.18M	-$175.54M	-38.4%	-24.5%	15.0%	-$0.16
NATR	Nature's Sunshine Products Inc Manufacturing · Year ended 2025-12-31 · USD	$480.14M	$20.45M	4.3%	12.7%	5.7%	$1.06
TVTX	Travere Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$490.73M	-$25.55M	-5.2%	-22.2%	110.5%	-$0.29
BBIO	BridgeBio Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$502.08M	-$732.94M	-146.0%	n/a	126.3%	-$3.78
MIRM	Mirum Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$521.31M	-$23.36M	-4.5%	-7.4%	54.7%	-$0.47
HCM	HUTCHMED (China) Ltd Manufacturing · Year ended 2025-12-31 · USD	$548.51M	$456.91M	83.3%	36.5%	-13.0%	$0.52
ORGO	Organogenesis Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$564.17M	$37.03M	6.6%	12.3%	17.0%	$0.15
INSM	Insmed Inc Manufacturing · Year ended 2025-12-31 · USD	$606.42M	-$1.28B	-210.5%	-172.8%	66.7%	-$6.42
OPK	Opko Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$606.88M	-$225.68M	-37.2%	-17.8%	-14.9%	-$0.30
TGTX	TG Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$616.29M	$447.18M	72.6%	69.0%	87.3%	$2.77
AXSM	Axsome Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$638.50M	-$183.17M	-28.7%	-207.5%	65.5%	-$3.68
RARE	Ultragenyx Pharmaceutical Inc. Manufacturing · Year ended 2025-12-31 · USD	$673.00M	-$575.00M	-85.4%	n/a	20.2%	-$5.83
KNSA	Kiniksa Pharmaceuticals International, plc Manufacturing · Year ended 2025-12-31 · USD	$677.56M	$59.01M	8.7%	10.4%	60.1%	$0.75
SUPN	Supernus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$718.95M	-$38.55M	-5.4%	-3.6%	8.6%	-$0.68
AMPH	Amphastar Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$719.89M	$98.09M	13.6%	12.4%	-1.7%	$2.03
PCRX	Pacira BioSciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$726.41M	$7.03M	1.0%	1.0%	3.6%	$0.16
EBS	Emergent BioSolutions Inc. Manufacturing · Year ended 2025-12-31 · USD	$742.90M	$52.60M	7.1%	10.1%	-28.8%	$0.93
CORT	Corcept Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$761.41M	$99.65M	13.1%	15.4%	12.8%	$0.82
COLL	Collegium Pharmaceutical, Inc Manufacturing · Year ended 2025-12-31 · USD	$780.57M	$62.87M	8.1%	20.8%	23.6%	$1.73
ARWR	Arrowhead Pharmaceuticals, Inc. Manufacturing · Year ended 2025-09-30 · USD	$829.45M	$30.11M	3.6%	6.0%	n/m	-$0.01
HRMY	Harmony Biosciences Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$868.45M	$158.69M	18.3%	18.2%	21.5%	$2.71
ANIP	ANI Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$883.37M	$78.34M	8.9%	14.5%	43.8%	$3.32
IONS	Ionis Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$943.71M	-$381.39M	-40.4%	-78.0%	33.8%	-$2.38

Rows per page: 2550 100